BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24625442)

  • 21. ATG7 deficiency promote apoptotic death induced by Cisplatin in human esophageal squamous cell carcinoma cells.
    Zhu L; Du H; Shi M; Chen Z; Hang J
    Bull Cancer; 2013; 100(7-8):15-21. PubMed ID: 23823853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells.
    Yoshioka M; Ohashi S; Ida T; Nakai Y; Kikuchi O; Amanuma Y; Matsubara J; Yamada A; Miyamoto S; Natsuizaka M; Nakagawa H; Chiba T; Seno H; Muto M
    J Exp Clin Cancer Res; 2017 Aug; 36(1):101. PubMed ID: 28764725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma.
    Zhang Q; Zhang C; He J; Guo Q; Hu D; Yang X; Wang J; Kang Y; She R; Wang Z; Li D; Huang G; Ma Z; Mao W; Zhou X; Xiao C; Sun X; Ma J
    Tumour Biol; 2015 Mar; 36(3):2135-42. PubMed ID: 25492480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cetuximab inhibits cisplatin-induced activation of EGFR signaling in esophageal squamous cell carcinoma.
    Kwon J; Yoon HJ; Kim JH; Lee TS; Song IH; Lee HW; Kang MC; Park JH
    Oncol Rep; 2014 Sep; 32(3):1188-92. PubMed ID: 24993015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bortezomib sensitizes esophageal squamous cancer cells to radiotherapy by suppressing the expression of HIF-1α and apoptosis proteins.
    Wang D; Qin Q; Jiang QJ; Wang DF
    J Xray Sci Technol; 2016 Apr; 24(4):639-46. PubMed ID: 27080362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensity-modulated radiotherapy combined with paclitaxel and platinum treatment regimens in locally advanced esophageal squamous cell carcinoma.
    Chen J; Su T; Lin Y; Wang B; Li J; Pan J; Chen C
    Clin Transl Oncol; 2018 Mar; 20(3):411-419. PubMed ID: 28779422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinostatic effects of platinum nanocolloid combined with gamma irradiation on human esophageal squamous cell carcinoma.
    Li Q; Tanaka Y; Saitoh Y; Tanaka H; Miwa N
    Life Sci; 2015 Apr; 127():106-14. PubMed ID: 25711430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomas.
    Khan T; Relitti N; Brindisi M; Magnano S; Zisterer D; Gemma S; Butini S; Campiani G
    Med Res Rev; 2020 May; 40(3):1002-1060. PubMed ID: 31742748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lobaplatin promotes radiosensitivity, induces apoptosis, attenuates cancer stemness and inhibits proliferation through PI3K/AKT pathway in esophageal squamous cell carcinoma.
    Pan S; Sun Y; Sui D; Yang T; Fu S; Wang J; Hui B; Xi R; He C; Zhang X
    Biomed Pharmacother; 2018 Jun; 102():567-574. PubMed ID: 29597090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study.
    Xu Y; Zheng Y; Sun X; Yu X; Gu J; Wu W; Zhang G; Hu J; Sun W; Mao W
    Oncotarget; 2015 Nov; 6(35):38429-39. PubMed ID: 26392415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.
    Raju U; Molkentine DP; Valdecanas DR; Deorukhkar A; Mason KA; Buchholz TA; Meyn RE; Ang KK; Skinner H
    Cancer Med; 2015 Jan; 4(1):65-74. PubMed ID: 25355701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of microRNA-98 increases radiosensitivity in esophageal squamous cell carcinoma.
    Jin YY; Chen QJ; Wei Y; Wang YL; Wang ZW; Xu K; He Y; Ma HB
    J Radiat Res; 2016 Sep; 57(5):468-476. PubMed ID: 27422937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: a randomized, open-label, phase IIb, 5-year study in Indian patients.
    Reddy BK; Lokesh V; Vidyasagar MS; Shenoy K; Babu KG; Shenoy A; Naveen T; Joseph B; Bonanthaya R; Nanjundappa ; Bapsy PP; Loknatha ; Shetty J; Prasad K; Tanvir Pasha CR
    Oral Oncol; 2014 May; 50(5):498-505. PubMed ID: 24613543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SOCS1 Gene Therapy Improves Radiosensitivity and Enhances Irradiation-Induced DNA Damage in Esophageal Squamous Cell Carcinoma.
    Sugase T; Takahashi T; Serada S; Fujimoto M; Hiramatsu K; Ohkawara T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Kishimoto T; Mori M; Doki Y; Naka T
    Cancer Res; 2017 Dec; 77(24):6975-6986. PubMed ID: 29042418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nimotuzumab significantly enhances chemosensitivity of
PC9 human lung adenocarcinoma cells to paclitaxel in vitro].
    Xiao Y; Cao B; Liang L
    Zhongguo Fei Ai Za Zhi; 2015 Feb; 18(2):98-103. PubMed ID: 25676404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs.
    Xie L; Song X; Yu J; Wei L; Song B; Wang X; Lv L
    J Exp Clin Cancer Res; 2009 May; 28(1):68. PubMed ID: 19470182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resveratrol-induced apoptosis is enhanced by inhibition of autophagy in esophageal squamous cell carcinoma.
    Tang Q; Li G; Wei X; Zhang J; Chiu JF; Hasenmayer D; Zhang D; Zhang H
    Cancer Lett; 2013 Aug; 336(2):325-37. PubMed ID: 23541682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nimotuzumab Combined with Chemotherapy as Second- or Later-line 
in the Treatment of Advanced Lung Squamous Cell Carcinoma].
    Luo Y; Li J; Wang Y; Hao X; Qu F
    Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):665-669. PubMed ID: 27760595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53.
    He T; Guo J; Song H; Zhu H; Di X; Min H; Wang Y; Chen G; Dai W; Ma J; Sun X; Ma J
    Pathol Oncol Res; 2018 Jan; 24(1):75-81. PubMed ID: 28341911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab.
    Jing Z; Gong L; Xie CY; Zhang L; Su HF; Deng X; Wu SX
    Radiother Oncol; 2009 Dec; 93(3):468-73. PubMed ID: 19744737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.